KAUFMAN, TX October 02, 2025 – PRESSADVANTAGE – ELIS Manufacturing & Packaging Solutions, a contract manufacturer and ...

Making Music, the leading membership organisation for leisure-time music in the UK has announced the winners of its 2025 ...

Chiesi Group & Arbor Biotechnologies enter global strategic partnership to develop novel rare disease gene editing programmes: Parma, Italy Tuesday, October 7, 2025, 14:00 Hrs [IS ...

CAS Academician, Prof. Jihong Yu, and her team from Jilin University developed a post-treatment strategy based on metal ...

Asbestos in a home can be a serious health risk. Learn more about the dangers of asbestos, where to look for it, and how to ...

Organ and cell transplantation remains a life-saving treatment for numerous debilitating diseases, yet it is continuously challenged by issues such as donor ...

In a thrilling clash that showcased the best of Spanish football, Isaac Romero emerged as the hero for Sevilla FC, delivering ...

Exclusive collaboration and license agreement for the development and global commercialization of Arbor’s clinical-stage gene ...

The first show at the new space, opening on 1 October, is inspired by the Eero Saarinen-designed US Embassy in Oslo ...

Despite significant advancements in diagnosis and treatment, cancer remains a major cause of mortality worldwide due to its heterogeneity, aggressiveness, ...

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for ...

CRISPR Therapeutics has developed SyNTase editing, a proprietary, next-generation, site-specific gene correction platform.